Real-World Use of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia: A Single-Centre Retrospective Descriptive Analysis
Clinical, Cosmetic and Investigational Dermatology · 2026-08 · Volume 19 · 1-15
DOI: 10.2147/ccid.s628527 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical, Cosmetic and Investigational Dermatology, 2026-08. Verfasst von Hamad Almutlaq. Beteiligte Einrichtung: Department of Dermatology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Zitieren
APA
Almutlaq, H. (2026). Real-World Use of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia: A Single-Centre Retrospective Descriptive Analysis. Clinical, Cosmetic and Investigational Dermatology, Volume 19, 1-15. https://doi.org/10.2147/ccid.s628527
Vancouver
Almutlaq H. Real-World Use of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia: A Single-Centre Retrospective Descriptive Analysis. Clinical, Cosmetic and Investigational Dermatology. 2026;Volume 19:1-15. doi:10.2147/ccid.s628527
BibTeX
@article{Almutlaq2026,
author = {Almutlaq, Hamad},
title = {Real-World Use of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia: A Single-Centre Retrospective Descriptive Analysis},
journal = {Clinical, Cosmetic and Investigational Dermatology},
year = {2026},
volume = {Volume 19},
pages = {1--15},
doi = {10.2147/ccid.s628527}
}
EUVIMED